⌘K

Home/Filings/4/0001062993-23-008770

4//SEC Filing

Borges Luis 4

Accession 0001062993-23-008770

CIK 0001850119other

View on SEC.gov Company Profile

Filed

Apr 4, 8:00 PM ET

Accepted

Apr 5, 4:27 PM ET

Size

6.5 KB

Accession

0001062993-23-008770

Insider Transaction Report

Form 4

Period: 2023-04-03

Century Therapeutics, Inc.IPSC

Chief Scientific Officer

Transactions

Exercise/Conversion
Common Stock
2023-04-03$1.03/sh+7,452$7,676→ 256,535 total
Exercise/Conversion
Stock Option (right to buy)
2023-04-03−7,452→ 0 total
Exercise: $1.03Exp: 2029-07-17→ Common Stock (7,452 underlying)

Footnotes (1)

[F1]As of the date hereof, these stock options are vested and currently exercisable.

Documents

1 file

4
form4.xmlPrimary
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Issuer

Century Therapeutics, Inc.

CIK 0001850119

Entity typeother

Related Parties

1

filerCIK 0001684015

Filing Metadata

Form type: 4
Filed: Apr 4, 8:00 PM ET
Accepted: Apr 5, 4:27 PM ET
Size: 6.5 KB

View on SEC.gov